|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.720 USD | +5.83% |
|
+2.39% | +249.63% |
| 06-29 | Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell 2000 Index | CI |
| 06-29 | Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 336M 294M 271M 252M 478M 32.05B 484M 3.24B 1.26B 15.73B 1.26B 1.23B 54.55B | P/E 2026 * |
-2.48x | P/E 2027 * | -2.82x |
|---|---|---|---|---|---|
| Enterprise Value | 125M 109M 100M 93.22M 177M 11.88B 179M 1.2B 468M 5.83B 468M 457M 20.21B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 6.71x |
| Free-Float |
77.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zentalis Pharmaceuticals, Inc.
| 1 day | +5.83% | ||
| 1 week | +2.39% | ||
| Current month | -2.68% | ||
| 1 month | +28.96% | ||
| 3 months | +75.46% | ||
| 6 months | +165.17% | ||
| Current year | +249.63% |
| 1 week | 4.28 |  | 4.95 |
| 1 month | 3.47 | | 5.11 |
| Current year | 1.32 | | 6.95 |
| 1 year | 1.18 | | 6.95 |
| 3 years | 1.01 | | 29.03 |
| 5 years | 1.01 | | 87.19 |
| 10 years | 1.01 | | 87.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 62 | 2024-11-12 |
| Director of Finance/CFO | - | 2024-11-12 | |
Ingmar Bruns
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-11-12 |
| Director | Title | Age | Since |
|---|---|---|---|
David Johnson
CHM | Chairman | 61 | 2022-05-15 |
Enoch Kariuki
BRD | Director/Board Member | 44 | 2021-02-08 |
Jan Skvarka
BRD | Director/Board Member | 59 | 2022-09-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-15 | Free | Chairman | 57,100 | 0.0802% | ||
| 06-15 | Free | Director | 57,100 | 0.0802% | ||
| 06-15 | Free | Director | 57,100 | 0.0802% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.83% | +2.39% | +274.60% | -83.06% | 317M | |
| -2.14% | +3.51% | +74.05% | +131.10% | 59.1B | |
| -0.93% | -2.54% | +73.64% | +93.71% | 55.19B | |
| -3.71% | -0.35% | -14.61% | -11.19% | 24.67B | |
| -0.05% | +6.49% | +14.05% | +451.36% | 24.19B | |
| -1.85% | +7.23% | +48.10% | -1.85% | 19.69B | |
| -2.19% | +6.34% | +40.74% | -29.60% | 17.56B | |
| +3.58% | +13.78% | +196.41% | +348.55% | 16.22B | |
| +4.91% | +20.18% | +44.61% | - | 14.84B | |
| -0.57% | +2.30% | +20.33% | +187.27% | 14.04B | |
| Average | +0.29% | +7.25% | +77.19% | +120.70% | 24.58B | |
| Weighted average by Cap. | -0.90% | +5.66% | +58.19% | +135.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 21.42M 18.76M 17.28M 16.04M 30.45M 2.04B 30.86M 207M 80.48M 1B 80.43M 78.66M 3.48B |
| Net income | -150M -131M -121M -112M -213M -14.32B -216M -1.45B -564M -7.03B -564M -551M -24.37B | -154M -135M -124M -115M -219M -14.68B -222M -1.49B -578M -7.21B -578M -565M -24.99B |
| Net Debt | -211M -185M -171M -158M -301M -20.17B -305M -2.04B -795M -9.9B -794M -777M -34.33B | -192M -168M -155M -144M -273M -18.33B -277M -1.86B -722M -9B -722M -706M -31.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | US$4.720 | +5.83% | 1,102,215 |
| 26-07-02 | US$4.460 | +2.41% | 583,661 |
| 26-07-01 | US$4.355 | -10.21% | 1,084,126 |
| 26-06-30 | US$4.850 | +5.21% | 1,853,549 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZNTL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
